Oscar John Benavidez, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 23 | 2019 | 4671 | 1.980 |
Why?
|
| Cardiac Surgical Procedures | 14 | 2019 | 3627 | 1.620 |
Why?
|
| Echocardiography | 8 | 2017 | 4989 | 0.790 |
Why?
|
| Diagnostic Errors | 3 | 2014 | 1265 | 0.730 |
Why?
|
| Health Resources | 3 | 2014 | 935 | 0.720 |
Why?
|
| Patient Admission | 3 | 2014 | 1367 | 0.670 |
Why?
|
| Patient Readmission | 2 | 2019 | 3271 | 0.440 |
Why?
|
| Postoperative Complications | 5 | 2019 | 15633 | 0.340 |
Why?
|
| Guideline Adherence | 5 | 2017 | 2220 | 0.340 |
Why?
|
| Conscious Sedation | 1 | 2014 | 532 | 0.340 |
Why?
|
| Angioplasty | 1 | 2011 | 355 | 0.320 |
Why?
|
| Hospital Mortality | 6 | 2019 | 5293 | 0.270 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 1179 | 0.260 |
Why?
|
| Hospitals, Pediatric | 2 | 2011 | 1860 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3205 | 0.240 |
Why?
|
| Hospital Charges | 2 | 2018 | 350 | 0.240 |
Why?
|
| Utilization Review | 2 | 2016 | 382 | 0.230 |
Why?
|
| Chest Pain | 2 | 2022 | 1091 | 0.210 |
Why?
|
| Sex Factors | 2 | 2016 | 10553 | 0.190 |
Why?
|
| Age Factors | 3 | 2016 | 18398 | 0.190 |
Why?
|
| Expeditions | 1 | 2021 | 11 | 0.190 |
Why?
|
| Risk Factors | 12 | 2019 | 74213 | 0.190 |
Why?
|
| Scurvy | 1 | 2021 | 35 | 0.180 |
Why?
|
| Databases, Factual | 4 | 2019 | 7967 | 0.180 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1166 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12059 | 0.170 |
Why?
|
| Washington | 1 | 2019 | 315 | 0.150 |
Why?
|
| Odds Ratio | 4 | 2016 | 9646 | 0.150 |
Why?
|
| Comorbidity | 3 | 2019 | 10508 | 0.150 |
Why?
|
| Pediatrics | 4 | 2017 | 3589 | 0.150 |
Why?
|
| Twins, Conjoined | 1 | 2017 | 41 | 0.150 |
Why?
|
| Florida | 1 | 2019 | 431 | 0.150 |
Why?
|
| Adolescent | 12 | 2022 | 88324 | 0.140 |
Why?
|
| New York | 1 | 2019 | 874 | 0.140 |
Why?
|
| Bioethical Issues | 1 | 2017 | 120 | 0.130 |
Why?
|
| Child, Preschool | 8 | 2019 | 42230 | 0.130 |
Why?
|
| Infant | 8 | 2019 | 36192 | 0.130 |
Why?
|
| Medical Assistance | 1 | 2016 | 108 | 0.130 |
Why?
|
| Length of Stay | 3 | 2019 | 6426 | 0.130 |
Why?
|
| Tricuspid Atresia | 1 | 2015 | 37 | 0.120 |
Why?
|
| California | 1 | 2019 | 1430 | 0.120 |
Why?
|
| Syncope | 1 | 2017 | 427 | 0.110 |
Why?
|
| Pulmonary Atresia | 1 | 2015 | 159 | 0.110 |
Why?
|
| Hospitalization | 2 | 2018 | 10721 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2019 | 26198 | 0.110 |
Why?
|
| Income | 2 | 2016 | 1877 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5336 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 415 | 0.110 |
Why?
|
| Child | 12 | 2019 | 80156 | 0.100 |
Why?
|
| Male | 18 | 2022 | 360842 | 0.100 |
Why?
|
| Outpatients | 2 | 2017 | 1597 | 0.100 |
Why?
|
| Female | 20 | 2019 | 392686 | 0.100 |
Why?
|
| Mass Screening | 1 | 2007 | 5428 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
| Humans | 30 | 2022 | 761572 | 0.090 |
Why?
|
| Reoperation | 2 | 2019 | 4303 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7391 | 0.090 |
Why?
|
| Insurance Carriers | 1 | 2011 | 156 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2015 | 594 | 0.080 |
Why?
|
| Classification | 1 | 2008 | 127 | 0.070 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 451 | 0.070 |
Why?
|
| Child Care | 1 | 2008 | 124 | 0.070 |
Why?
|
| Hospital Costs | 1 | 2014 | 947 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2011 | 458 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3416 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2008 | 573 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 1755 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 59255 | 0.070 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2008 | 261 | 0.070 |
Why?
|
| Time Factors | 4 | 2016 | 39970 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2019 | 80646 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2011 | 10090 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3579 | 0.070 |
Why?
|
| Cardiology | 1 | 2017 | 1656 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2008 | 957 | 0.060 |
Why?
|
| Aneurysm | 1 | 2008 | 337 | 0.060 |
Why?
|
| Middle Aged | 7 | 2019 | 220920 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 743 | 0.060 |
Why?
|
| Adult | 7 | 2019 | 221203 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2373 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2008 | 591 | 0.060 |
Why?
|
| National Health Programs | 1 | 2007 | 440 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 1204 | 0.050 |
Why?
|
| Quality Control | 2 | 2016 | 832 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20099 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3807 | 0.050 |
Why?
|
| United States | 5 | 2017 | 72335 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3245 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2014 | 1940 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2008 | 722 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2006 | 600 | 0.050 |
Why?
|
| Morbidity | 1 | 2007 | 1750 | 0.050 |
Why?
|
| Antarctic Regions | 1 | 2021 | 13 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3408 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2014 | 2498 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2008 | 1530 | 0.050 |
Why?
|
| Boston | 1 | 2014 | 9326 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2017 | 23996 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14666 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2014 | 3801 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2169 | 0.040 |
Why?
|
| Ethics Committees, Clinical | 1 | 2017 | 56 | 0.040 |
Why?
|
| Body Weight | 1 | 2008 | 4618 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15732 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2008 | 3905 | 0.030 |
Why?
|
| Abnormalities, Multiple | 2 | 2017 | 1423 | 0.030 |
Why?
|
| E-Selectin | 1 | 1998 | 576 | 0.030 |
Why?
|
| Abortion, Eugenic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 2001 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2007 | 3242 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2017 | 2781 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 64684 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 683 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13255 | 0.030 |
Why?
|
| Fetal Death | 1 | 2015 | 435 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2008 | 4330 | 0.030 |
Why?
|
| Microcirculation | 1 | 1998 | 1272 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1835 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2017 | 783 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2017 | 54426 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 7827 | 0.020 |
Why?
|
| Depression | 1 | 2011 | 8124 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1186 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2015 | 2927 | 0.020 |
Why?
|
| Leukocytes | 1 | 1998 | 2026 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 15501 | 0.020 |
Why?
|
| Guatemala | 1 | 2007 | 159 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 3577 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2006 | 318 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4431 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 26127 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 897 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2775 | 0.010 |
Why?
|
| Angiography | 1 | 2008 | 1595 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3849 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7396 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39107 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2015 | 3233 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 1428 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 1400 | 0.010 |
Why?
|
| Exercise Test | 1 | 2006 | 2127 | 0.010 |
Why?
|
| Incidence | 1 | 2015 | 21355 | 0.010 |
Why?
|
| Developing Countries | 1 | 2007 | 2885 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 8633 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12725 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29876 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1998 | 3088 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2206 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 4352 | 0.000 |
Why?
|
| Cell Movement | 1 | 1998 | 5205 | 0.000 |
Why?
|
| Gene Expression | 1 | 1998 | 7581 | 0.000 |
Why?
|
| Skin | 1 | 1998 | 4484 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1998 | 14416 | 0.000 |
Why?
|
| Animals | 2 | 2008 | 168467 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 36429 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 81533 | 0.000 |
Why?
|